- Merck & Co., Inc., headquartered in Rahway, New Jersey, is a leading global pharmaceutical company known for its innovative healthcare solutions, particularly in oncology, animal health, and vaccines, with worldwide sales reaching $65.0 billion in 2025.
- In 2026, Merck launched the first bio-based solvent portfolio for high-performance liquid chromatography, which reduces CO2 emissions by 25.9% compared to traditional solvents, showcasing its commitment to sustainability and innovation.
- Key products include KEYTRUDA, which generated $31.7 billion in sales in 2025, and partnerships with the U.S. government to enhance access to medicines, indicating strong relationships with both healthcare providers and regulatory bodies.
- Merck's ideal buyers are healthcare professionals and institutions seeking reliable, innovative pharmaceutical solutions that address critical health challenges, particularly in oncology and chronic diseases, making it essential for sales teams to engage with these stakeholders now as they seek to expand their treatment options.
The workforce is organized across 18 departments, with a notable concentration in Information Technology, which employs 75 individuals, and Operations, with 73 employees. Community and Social Services also plays a significant role, contributing 64 staff members. This distribution indicates a balanced functional mix, supporting both technical and operational needs within the organization.
The company operates across 123 locations, with a significant presence in Kenilworth, NJ (18 employees), Philadelphia, PA (16), and New York, NY (15). The 'Other' category accounts for 358 employees, highlighting a distributed workforce across various regions. This geographic distribution suggests a strategic approach to operational flexibility and resource allocation.
Get more information on people & companies with Unify
